Kymera Therapeutics logo

Senior Director or Executive Director, Toxicology

Kymera Therapeutics
Full-time
Remote friendly (Watertown, MA)
United States
$235,000 - $335,000 USD yearly
Clinical Research and Development

Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now โ€” JobsAI.

Role Summary

Senior Director or Executive Director, Toxicology role focused on nonclinical safety strategy and execution for Kymeraโ€šร„รดs degrader programs, spanning discovery to advanced clinical development.

Responsibilities

  • Provide expert nonclinical safety support, guidance, and strategy for Kymeraโ€šร„รดs degrader projects, from discovery through advanced clinical programs.
  • Act as the key nonclinical safety representative on cross-functional development teams and contribute scientific and regulatory expertise to drive integrated program decision-making.
  • Develop nonclinical safety strategies and plans for programs at all stages of drug development.
  • Oversee toxicology and safety pharmacology studies at multiple Contract Research Organizations.
  • Design and execute GLP, non-GLP, investigative, and in vitro studies; review protocols and reports to ensure submission-ready documents for regulatory authorities.
  • Prepare verbal and written summaries for internal discussions; collaborate with the Preclinical Development team to address safety issues and partner with project teams.
  • Lead authorship of toxicology and/or safety pharmacology sections of regulatory documents (e.g., pre-IND briefing documents, IND, IBs).
  • Represent the company at meetings with regulatory agencies and present summary data to project teams and Kymera senior leadership.
  • Provide leadership and mentorship to junior toxicology or preclinical staff; foster a culture of scientific excellence.

Qualifications

  • PhD in Toxicology or Pharmacology, DVM, or related field; DABT or ERT certification preferred but not required.
  • 12+ years in the biopharma industry in a Toxicology or Pathology role, including โ€šรขโ€ข5 years supporting small molecule project teams leading preclinical development strategy for IND-through-Phase II programs.
  • Experience with EMA and FDA CTA/IND submissions and regulatory interactions.
  • Experience partnering with internal stakeholders to develop comprehensive preclinical safety approaches as part of program strategy.
  • Strong verbal and written communication skills; ability to influence and present to executive leadership and regulatory agencies.
  • Experience working with outsourced studies.
  • Ability to perform in a fast-paced and dynamic environment.

Skills

  • Nonclinical safety strategy development
  • Toxicology and safety pharmacology study design and oversight
  • Regulatory submission preparation and interactions
  • Cross-functional leadership and mentorship
  • External communications with regulatory bodies

Education

  • PhD in Toxicology or Pharmacology, DVM, or related field (as applicable per role requirements)

Additional Requirements

  • Travel or physical demands not specified as essential in the provided content.